| 0 |
GASTRITIS ALCOHOLIC |
1 |
0.0500 |
| 1 |
ANORECTAL VARICES |
1 |
0.0238 |
| 2 |
STOMA SITE RASH |
1 |
0.0120 |
| 3 |
EYE INFARCTION |
1 |
0.0100 |
| 4 |
DEVICE ALLERGY |
1 |
0.0040 |
| 5 |
MESENTERIC PANNICULITIS |
1 |
0.0033 |
| 6 |
IODINE ALLERGY |
1 |
0.0030 |
| 7 |
CARDIOVASCULAR SYMPTOM |
1 |
0.0026 |
| 8 |
DYSPRAXIA |
1 |
0.0018 |
| 9 |
ALLERGY TO METALS |
1 |
0.0016 |
| 10 |
INHALATION THERAPY |
1 |
0.0016 |
| 11 |
POST PROCEDURAL SEPSIS |
1 |
0.0015 |
| 12 |
ALCOHOL WITHDRAWAL SYNDROME |
1 |
0.0011 |
| 13 |
SPINAL CORD NEOPLASM |
1 |
0.0011 |
| 14 |
BLOOD TRIGLYCERIDES ABNORMAL |
1 |
0.0011 |
| 15 |
FOLLICULAR LYMPHOMA |
1 |
0.0011 |
| 16 |
STOMA COMPLICATION |
1 |
0.0010 |
| 17 |
STOMA SITE INFECTION |
1 |
0.0008 |
| 18 |
BODY MASS INDEX INCREASED |
1 |
0.0007 |
| 19 |
MAST CELL ACTIVATION SYNDROME |
1 |
0.0007 |
| 20 |
GLUTEN SENSITIVITY |
1 |
0.0007 |
| 21 |
ANTICHOLINERGIC SYNDROME |
1 |
0.0006 |
| 22 |
HISTOPLASMOSIS |
1 |
0.0006 |
| 23 |
ESSENTIAL HYPERTENSION |
1 |
0.0005 |
| 24 |
CONTRAST MEDIA ALLERGY |
1 |
0.0005 |
| 25 |
LYMPHADENOPATHY MEDIASTINAL |
1 |
0.0005 |
| 26 |
ANORECTAL DISORDER |
1 |
0.0005 |
| 27 |
ATRIAL THROMBOSIS |
1 |
0.0005 |
| 28 |
ALCOHOLISM |
2 |
0.0005 |
| 29 |
EYELID IRRITATION |
1 |
0.0004 |
| 30 |
PSYCHOMOTOR SKILLS IMPAIRED |
1 |
0.0004 |
| 31 |
ALCOHOL ABUSE |
1 |
0.0004 |
| 32 |
ALCOHOL POISONING |
1 |
0.0004 |
| 33 |
STOMA SITE DISCHARGE |
1 |
0.0004 |
| 34 |
RED BLOOD CELL COUNT INCREASED |
1 |
0.0004 |
| 35 |
EMERGENCY CARE |
1 |
0.0003 |
| 36 |
INFUSION SITE PRURITUS |
1 |
0.0003 |
| 37 |
PEPTIC ULCER |
1 |
0.0003 |
| 38 |
LEFT VENTRICULAR FAILURE |
1 |
0.0003 |
| 39 |
PANIC DISORDER |
1 |
0.0003 |
| 40 |
OBSTRUCTION |
1 |
0.0003 |
| 41 |
INTRACRANIAL ANEURYSM |
1 |
0.0002 |
| 42 |
GALLBLADDER OPERATION |
1 |
0.0002 |
| 43 |
RECURRENT CANCER |
1 |
0.0002 |
| 44 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 45 |
PARKINSONISM |
2 |
0.0002 |
| 46 |
ORGANISING PNEUMONIA |
1 |
0.0002 |
| 47 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 48 |
ERYTHEMA OF EYELID |
1 |
0.0002 |
| 49 |
CARDIAC VALVE DISEASE |
1 |
0.0002 |
| 50 |
HYPERCHLORHYDRIA |
1 |
0.0002 |
| 51 |
INGUINAL HERNIA |
1 |
0.0002 |
| 52 |
POISONING |
2 |
0.0002 |
| 53 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 54 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 55 |
TROPONIN INCREASED |
1 |
0.0001 |
| 56 |
GENERALISED TONIC-CLONIC SEIZURE |
2 |
0.0001 |
| 57 |
ERECTILE DYSFUNCTION |
3 |
0.0001 |
| 58 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 59 |
URINE OUTPUT DECREASED |
1 |
0.0001 |
| 60 |
BLOOD CALCIUM INCREASED |
1 |
0.0001 |
| 61 |
IRON DEFICIENCY ANAEMIA |
1 |
0.0001 |
| 62 |
DEMENTIA |
3 |
0.0001 |
| 63 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 64 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 65 |
PRODUCT ADMINISTRATION ERROR |
2 |
0.0001 |
| 66 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 67 |
BIPOLAR DISORDER |
1 |
0.0001 |
| 68 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 69 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 70 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 71 |
BRAIN OEDEMA |
1 |
0.0001 |
| 72 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 73 |
UNRESPONSIVE TO STIMULI |
2 |
0.0001 |
| 74 |
HIATUS HERNIA |
1 |
0.0001 |
| 75 |
SOPOR |
1 |
0.0001 |
| 76 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 77 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 78 |
RESPIRATORY ARREST |
2 |
0.0001 |
| 79 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 80 |
HUNGER |
1 |
0.0001 |
| 81 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 82 |
SUBDURAL HAEMATOMA |
1 |
0.0001 |
| 83 |
DYSSTASIA |
2 |
0.0001 |
| 84 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 85 |
PULMONARY MASS |
1 |
0.0001 |
| 86 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 87 |
DRUG DISPENSING ERROR |
1 |
0.0001 |
| 88 |
TINNITUS |
3 |
0.0001 |
| 89 |
INJECTION SITE RASH |
2 |
0.0001 |
| 90 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 91 |
OBESITY |
1 |
0.0001 |
| 92 |
DRY MOUTH |
5 |
0.0001 |
| 93 |
COMPLETED SUICIDE |
5 |
0.0001 |
| 94 |
METRORRHAGIA |
1 |
0.0001 |
| 95 |
NIGHTMARE |
2 |
0.0001 |
| 96 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 97 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 98 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 99 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 100 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 101 |
INCREASED APPETITE |
1 |
0.0001 |
| 102 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 103 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 104 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 105 |
SKIN FISSURES |
1 |
0.0001 |
| 106 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 107 |
FEEDING DISORDER |
1 |
0.0000 |
| 108 |
POLLAKIURIA |
2 |
0.0000 |
| 109 |
WITHDRAWAL SYNDROME |
2 |
0.0000 |
| 110 |
MOUTH ULCERATION |
1 |
0.0000 |
| 111 |
RETCHING |
1 |
0.0000 |
| 112 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 113 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 114 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 115 |
BLOOD CHOLESTEROL INCREASED |
2 |
0.0000 |
| 116 |
DYSPEPSIA |
4 |
0.0000 |
| 117 |
HOT FLUSH |
3 |
0.0000 |
| 118 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 119 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 120 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
2 |
0.0000 |
| 121 |
ECZEMA |
2 |
0.0000 |
| 122 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 123 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 124 |
DRUG ABUSE |
3 |
0.0000 |
| 125 |
FEELING COLD |
1 |
0.0000 |
| 126 |
PANCYTOPENIA |
2 |
0.0000 |
| 127 |
EYE PAIN |
2 |
0.0000 |
| 128 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 129 |
NEEDLE ISSUE |
1 |
0.0000 |
| 130 |
INTENTIONAL PRODUCT MISUSE |
3 |
0.0000 |
| 131 |
ASCITES |
1 |
0.0000 |
| 132 |
BLADDER CANCER |
2 |
0.0000 |
| 133 |
RENAL INJURY |
1 |
0.0000 |
| 134 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 135 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 136 |
HEAD INJURY |
1 |
0.0000 |
| 137 |
MIGRAINE |
3 |
0.0000 |
| 138 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 139 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 140 |
VIRAL INFECTION |
1 |
0.0000 |
| 141 |
INJECTION SITE PRURITUS |
2 |
0.0000 |
| 142 |
TOXICITY TO VARIOUS AGENTS |
5 |
0.0000 |
| 143 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 144 |
PRODUCT QUALITY ISSUE |
4 |
0.0000 |
| 145 |
DELIRIUM |
1 |
0.0000 |
| 146 |
HYPOXIA |
1 |
0.0000 |
| 147 |
PLATELET COUNT DECREASED |
3 |
0.0000 |
| 148 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 149 |
RESTLESSNESS |
1 |
0.0000 |
| 150 |
INJECTION SITE MASS |
1 |
0.0000 |
| 151 |
EYE SWELLING |
1 |
0.0000 |
| 152 |
DYSARTHRIA |
1 |
0.0000 |
| 153 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 154 |
ACUTE KIDNEY INJURY |
4 |
0.0000 |
| 155 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 156 |
SEIZURE |
3 |
0.0000 |
| 157 |
PROSTATE CANCER |
2 |
0.0000 |
| 158 |
SOMNOLENCE |
5 |
0.0000 |
| 159 |
CONFUSIONAL STATE |
4 |
0.0000 |
| 160 |
DYSKINESIA |
1 |
0.0000 |
| 161 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 162 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 163 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 164 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 165 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 166 |
OVERDOSE |
5 |
0.0000 |
| 167 |
DRUG WITHDRAWAL SYNDROME |
2 |
0.0000 |
| 168 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 169 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 170 |
ADVERSE EVENT |
2 |
0.0000 |
| 171 |
HYPOKALAEMIA |
1 |
0.0000 |
| 172 |
BACK PAIN |
5 |
0.0000 |
| 173 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 174 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 175 |
COMA |
1 |
0.0000 |
| 176 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 177 |
SINUSITIS |
2 |
0.0000 |
| 178 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 179 |
DERMATITIS ATOPIC |
1 |
0.0000 |
| 180 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 181 |
DRUG DEPENDENCE |
3 |
0.0000 |
| 182 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 183 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 184 |
DIZZINESS |
9 |
0.0000 |
| 185 |
NECK PAIN |
1 |
0.0000 |
| 186 |
HYPONATRAEMIA |
1 |
0.0000 |
| 187 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 188 |
ANXIETY |
5 |
0.0000 |
| 189 |
CONVULSION |
1 |
0.0000 |
| 190 |
EYE IRRITATION |
1 |
0.0000 |
| 191 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 192 |
WHEEZING |
1 |
0.0000 |
| 193 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 194 |
IRRITABILITY |
1 |
0.0000 |
| 195 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 196 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 197 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 198 |
BLOOD GLUCOSE INCREASED |
3 |
0.0000 |
| 199 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 200 |
RHINORRHOEA |
1 |
0.0000 |
| 201 |
DEHYDRATION |
2 |
0.0000 |
| 202 |
VISION BLURRED |
2 |
0.0000 |
| 203 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 204 |
INJURY |
1 |
0.0000 |
| 205 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 206 |
AGITATION |
1 |
0.0000 |
| 207 |
BRONCHITIS |
1 |
0.0000 |
| 208 |
HALLUCINATION |
1 |
0.0000 |
| 209 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 210 |
DIABETES MELLITUS |
1 |
0.0000 |
| 211 |
HOSPITALISATION |
2 |
0.0000 |
| 212 |
HEADACHE |
8 |
0.0000 |
| 213 |
ARTHRITIS |
1 |
0.0000 |
| 214 |
PARAESTHESIA |
2 |
0.0000 |
| 215 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 216 |
CARDIAC ARREST |
1 |
0.0000 |
| 217 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 218 |
BALANCE DISORDER |
1 |
0.0000 |
| 219 |
FATIGUE |
9 |
0.0000 |
| 220 |
TACHYCARDIA |
1 |
0.0000 |
| 221 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 222 |
WEIGHT DECREASED |
3 |
0.0000 |
| 223 |
ASTHENIA |
4 |
0.0000 |
| 224 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 225 |
CONTUSION |
1 |
0.0000 |
| 226 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 227 |
PRODUCT DOSE OMISSION ISSUE |
3 |
0.0000 |
| 228 |
SYNCOPE |
1 |
0.0000 |
| 229 |
FLUSHING |
1 |
0.0000 |
| 230 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 231 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 232 |
HAEMORRHAGE |
1 |
0.0000 |
| 233 |
HYPERTENSION |
2 |
0.0000 |
| 234 |
MALAISE |
4 |
0.0000 |
| 235 |
WEIGHT INCREASED |
2 |
0.0000 |
| 236 |
DYSPNOEA |
5 |
0.0000 |
| 237 |
DEPRESSION |
2 |
0.0000 |
| 238 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 239 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 240 |
PALPITATIONS |
1 |
0.0000 |
| 241 |
CHILLS |
1 |
0.0000 |
| 242 |
VOMITING |
4 |
0.0000 |
| 243 |
FEELING ABNORMAL |
2 |
0.0000 |
| 244 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 245 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 246 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 247 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 248 |
HYPERHIDROSIS |
1 |
0.0000 |
| 249 |
DIARRHOEA |
5 |
0.0000 |
| 250 |
DRUG INEFFECTIVE |
10 |
0.0000 |
| 251 |
RENAL FAILURE |
1 |
0.0000 |
| 252 |
INSOMNIA |
2 |
0.0000 |
| 253 |
COUGH |
2 |
0.0000 |
| 254 |
INFECTION |
1 |
0.0000 |
| 255 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 256 |
HYPOAESTHESIA |
1 |
0.0000 |
| 257 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 258 |
PAIN |
4 |
0.0000 |
| 259 |
NAUSEA |
5 |
0.0000 |
| 260 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 261 |
TREMOR |
1 |
0.0000 |
| 262 |
FALL |
2 |
0.0000 |
| 263 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 264 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 265 |
CHEST PAIN |
1 |
0.0000 |
| 266 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 267 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 268 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 269 |
PRURITUS |
2 |
0.0000 |
| 270 |
HYPOTENSION |
1 |
0.0000 |
| 271 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 272 |
ERYTHEMA |
1 |
0.0000 |
| 273 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 274 |
CONSTIPATION |
1 |
0.0000 |
| 275 |
OFF LABEL USE |
4 |
0.0000 |
| 276 |
DECREASED APPETITE |
1 |
0.0000 |
| 277 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 278 |
DEATH |
3 |
0.0000 |
| 279 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 280 |
PNEUMONIA |
1 |
0.0000 |
| 281 |
PYREXIA |
1 |
0.0000 |
| 282 |
ARTHRALGIA |
1 |
0.0000 |
| 283 |
RASH |
1 |
0.0000 |